The Prevalence of Fibromyalgia in Adults at Al-Karak Jordan a Cross-sectional Study

• Sponsor: Mutah University (Other)
• Overall Status: Recruiting
• CT.gov ID: NCT06103058
• Collaborator: (none)
• Enrollment: 965
• Location: 1
• Anticipated Duration (Months): 19.7
• Patients Per Site Per Month: 49

Study Details

Study Description

Brief Summary

Fibromyalgia is a chronic and intricate musculoskeletal disorder characterized by widespread pain, fatigue, and tenderness in specific anatomical regions. Although its prevalence varies among populations, understanding the prevalence in different geographical areas is crucial for healthcare planning. This cross-sectional study aims to determine the prevalence of fibromyalgia in adults residing in Al-Karak, Jordan. The city's unique demographic and environmental characteristics may influence the occurrence of fibromyalgia among its adult population. The study aims to address gaps in knowledge, provide localized insights, and shed light on fibromyalgia's burden on the community's health. Accurate prevalence data aids healthcare planning and resource allocation.

Condition or Disease	Intervention/Treatment	Phase
Fibromyalgia; Orthopedic Disorder	Other: Cross sectional

Study Design

• Study Type: Observational [Patient Registry]
• Anticipated Enrollment: 965 participants
• Observational Model: Other
• Time Perspective: Cross-Sectional
• Official Title: The Prevalence of Fibromyalgia in Adults at Al-Karak Jordan a Cross-sectional Study
• Actual Study Start Date: May 12, 2023
• Anticipated Primary Completion Date: Dec 31, 2024
• Anticipated Study Completion Date: Dec 31, 2024

Arms and Interventions

Arm	Intervention/Treatment
Positive for fibromyalgia 26.5% prevalence of fibromyalgia
Negative for fibromyalgia 26.5% prevalence of fibromyalgia	Other: Cross sectional; Cross sectional

Outcome Measures

Primary Outcome Measures

1. Cross sectional [2 years]

   Outcome measurements

Eligibility Criteria

Criteria

• Ages Eligible for Study: 1 Month to 100 Years
• Sexes Eligible for Study: All
• Accepts Healthy Volunteers: Yes

Using google forms, this cross-sectional study was carried out, and the participants were reached via social media platforms (5)

. Participants' autonomy was maintained, and no direct benefit was gained in return for filling out the questionnaire. The ethics committee at the Faculty of Medicine, Mutah University, Karak, Jordan, provided the required ethical approval prior to the initiation of this study. Moreover, the committee ensured that the study was designed according to the principles of the Declaration of Helsinki (Date: 13 February 2023. Reference number: 992023). In this study, the authors targeted Karak government citizens, in Jordan. Accordingly, the required sample size to achieve a 99% Confidence interval was 663 participants.

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Mutah University	Al-Karak		Jordan	61710

Sponsors and Collaborators

• Mutah University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

• Responsible Party: Mohammad Abu-Jeyyab, Mutah university, Mutah University
• ClinicalTrials.gov Identifier: NCT06103058
• Other Study ID Numbers: 20235012
• First Posted: Oct 26, 2023
• Last Update Posted: Oct 26, 2023
• Last Verified: Oct 1, 2023

• Individual Participant Data (IPD) Sharing Statement: Undecided
• Plan to Share IPD: Undecided
• Studies a U.S. FDA-regulated Drug Product: No
• Studies a U.S. FDA-regulated Device Product: No
• Additional relevant MeSH terms: Fibromyalgia; Myofascial Pain Syndromes; Musculoskeletal Diseases

Study Results

No Results Posted as of Oct 26, 2023